Cost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modelling study

<p>Background Cost-effectiveness analysis needs to be considered when introducing new tools and treatments to clinical services. The number of new assessment tools in mental health has rapidly expanded, including in suicide risk assessment. Such suicide-based assessments, when linked to preven...

Full description

Bibliographic Details
Main Authors: Botchway, S, Tsiachristas, A, Pollard, J, Fazel, S
Format: Journal article
Language:English
Published: Cambridge University Press 2022
_version_ 1797109244246360064
author Botchway, S
Tsiachristas, A
Pollard, J
Fazel, S
author_facet Botchway, S
Tsiachristas, A
Pollard, J
Fazel, S
author_sort Botchway, S
collection OXFORD
description <p>Background Cost-effectiveness analysis needs to be considered when introducing new tools and treatments to clinical services. The number of new assessment tools in mental health has rapidly expanded, including in suicide risk assessment. Such suicide-based assessments, when linked to preventative interventions, are integral to high quality mental health care for people with severe mental illness (SMI). We examined the cost implications of implementing OXMIS, an evidence-based,scalable suicide risk assessment tool that provides probabilistic estimates of suicide risk over 12 months for people with SMI in England. Methods We developed a decision analytic model using secondary data to estimate the potential costeffectiveness of incorporating OxMIS into clinical decision-making in secondary care as compared to usual care. Cost-effectiveness was measured in terms of costs per quality adjusted life years (QALYs) gained. Uncertainty was addressed with deterministic and probabilistic sensitivity analysis. Results Conducting suicide risk assessment with OxMIS was potentially cheaper than clinical risk assessment alone by &pound;250 (95% confidence interval, -786;31) to &pound;599 (-1,321;-156) (in 2020-2021 prices) per person with SMI and associated with a small increase in quality of life (0.01 (-0.03;0.05) to 0.01 QALY, (-0.04;0.07)). The estimated incremental cost-effectiveness ratio of implementing OxMIS was cost saving. Using probabilistic sensitivity analysis, 99.96% of 10,000 simulations remained cost saving. Conclusion Cost-effectiveness analysis can be conducted on risk prediction models. Implementing one such model that focuses on suicide risk in a high-risk population can lead to cost savings and improved health outcomes, especially if explicitly linked to preventative treatments.</p>
first_indexed 2024-03-07T07:39:03Z
format Journal article
id oxford-uuid:36e31b94-8e9b-48d7-a7b8-64885c775404
institution University of Oxford
language English
last_indexed 2024-03-07T07:39:03Z
publishDate 2022
publisher Cambridge University Press
record_format dspace
spelling oxford-uuid:36e31b94-8e9b-48d7-a7b8-64885c7754042023-04-06T09:36:40ZCost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modelling studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:36e31b94-8e9b-48d7-a7b8-64885c775404EnglishSymplectic ElementsCambridge University Press2022Botchway, STsiachristas, APollard, JFazel, S<p>Background Cost-effectiveness analysis needs to be considered when introducing new tools and treatments to clinical services. The number of new assessment tools in mental health has rapidly expanded, including in suicide risk assessment. Such suicide-based assessments, when linked to preventative interventions, are integral to high quality mental health care for people with severe mental illness (SMI). We examined the cost implications of implementing OXMIS, an evidence-based,scalable suicide risk assessment tool that provides probabilistic estimates of suicide risk over 12 months for people with SMI in England. Methods We developed a decision analytic model using secondary data to estimate the potential costeffectiveness of incorporating OxMIS into clinical decision-making in secondary care as compared to usual care. Cost-effectiveness was measured in terms of costs per quality adjusted life years (QALYs) gained. Uncertainty was addressed with deterministic and probabilistic sensitivity analysis. Results Conducting suicide risk assessment with OxMIS was potentially cheaper than clinical risk assessment alone by &pound;250 (95% confidence interval, -786;31) to &pound;599 (-1,321;-156) (in 2020-2021 prices) per person with SMI and associated with a small increase in quality of life (0.01 (-0.03;0.05) to 0.01 QALY, (-0.04;0.07)). The estimated incremental cost-effectiveness ratio of implementing OxMIS was cost saving. Using probabilistic sensitivity analysis, 99.96% of 10,000 simulations remained cost saving. Conclusion Cost-effectiveness analysis can be conducted on risk prediction models. Implementing one such model that focuses on suicide risk in a high-risk population can lead to cost savings and improved health outcomes, especially if explicitly linked to preventative treatments.</p>
spellingShingle Botchway, S
Tsiachristas, A
Pollard, J
Fazel, S
Cost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modelling study
title Cost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modelling study
title_full Cost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modelling study
title_fullStr Cost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modelling study
title_full_unstemmed Cost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modelling study
title_short Cost-effectiveness of implementing a suicide prediction tool (OxMIS) in severe mental illness: economic modelling study
title_sort cost effectiveness of implementing a suicide prediction tool oxmis in severe mental illness economic modelling study
work_keys_str_mv AT botchways costeffectivenessofimplementingasuicidepredictiontooloxmisinseverementalillnesseconomicmodellingstudy
AT tsiachristasa costeffectivenessofimplementingasuicidepredictiontooloxmisinseverementalillnesseconomicmodellingstudy
AT pollardj costeffectivenessofimplementingasuicidepredictiontooloxmisinseverementalillnesseconomicmodellingstudy
AT fazels costeffectivenessofimplementingasuicidepredictiontooloxmisinseverementalillnesseconomicmodellingstudy